XML 35 R40.htm IDEA: XBRL DOCUMENT v3.2.0.727
Equity Instruments - Vyrix Stock Option Activity (Detail) - Vyrix Pharmaceuticals [Member] - USD ($)
9 Months Ended 12 Months Ended
Mar. 31, 2015
Jun. 30, 2014
Jun. 30, 2013
Number of Options      
Number of Options, Beginning Balance 117,053    
Number of Options, Granted   117,053  
Number of Options, Exercised 0 0 0
Number of Options, Forfeited/Cancelled 0 0 0
Number of Options, Ending Balance 117,053 117,053  
Number of Options, Exercisable 58,526    
Number of Options, Available for grant 499,014    
Weighted Average Exercise Price      
Weighted Average Exercise Price, Beginning Balance   $ 5.68  
Weighted Average Exercise Price, Granted   5.68  
Weighted Average Exercise Price, Exercised $ 0 0 $ 0
Weighted Average Exercise Price, Forfeited/Cancelled 0 $ 0 0
Weighted Average Exercise Price, Ending Balance 5.68   $ 5.68
Weighted average exercise price, Exercisable $ 5.68    
Weighted Average Remaining Contractual Life      
Weighted Average Remaining Contractual Life, Outstanding 8 years 9 months 15 days 9 years 6 months 15 days  
Weighted Average Remaining Contractual Life, Exercisable 8 years 9 months 15 days    
Aggregate Intrinsic Value      
Aggregate Intrinsic Value, Beginning Balance $ 417,000    
Aggregate Intrinsic Value, Ending Balance 417,000 $ 417,000  
Aggregate Intrinsic Value, Exercisable $ 208,000